C6orf72 Inhibitors
Chemical inhibitors of C6orf72 can modulate its function through various mechanisms, primarily by altering the pathways in which this protein is involved. Z-VAD-FMK, as a pan-caspase inhibitor, can inhibit apoptosis wherein C6orf72 may play a role. This inhibition can stabilize cellular systems by reducing the hyperactivation of autophagy pathways. The compounds 3-MA and Spautin-1 target the autophagy initiation process, with 3-MA inhibiting phosphatidylinositol 3-kinases involved in autophagosome formation, and Spautin-1 promoting the degradation of class III PI3 kinase Vps34. These actions can lead to a reduction in C6orf72-mediated autophagy by disrupting the formation and maturation of autophagosomes.
Inhibitors that target the PI3K/Akt pathway, such as LY294002 and Wortmannin, prevent the activation of downstream proteins that could be involved in C6orf72 signaling. By blocking this pathway, these inhibitors can reduce C6orf72 activity within this context. Additionally, Saracatinib, a Src kinase inhibitor, can disrupt various signaling pathways, including those related to autophagy and cytoskeletal dynamics, potentially inhibiting C6orf72 functions. mTOR inhibitors like Sapanisertib and Rapamycin suppress the mTOR signaling pathway, which is crucial for autophagy and cellular growth, thus inhibiting the autophagic pathway involving C6orf72. Bafilomycin A1 and Chloroquine impair lysosomal function; Bafilomycin A1 by inhibiting V-ATPase and blocking autophagosome-lysosome fusion, and Chloroquine by raising lysosomal pH and impairing autophagic degradation. These actions can inhibit C6orf72-related autophagic activities by disrupting the final stages of the autophagy process. Cyclosporin A inhibits calcineurin, potentially affecting calcium signaling pathways and leading to the modulation of C6orf72 functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
Z-VAD-FMK is a pan-caspase inhibitor that can inhibit apoptosis. Since C6orf72 is implicated in the regulation of autophagy and possibly apoptosis, inhibition of caspases can stabilize cellular systems, potentially reducing the hyperactivation of autophagy pathways where C6orf72 might play a role. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine (3-MA) inhibits phosphatidylinositol 3-kinases, which are involved in autophagosome formation. Given that C6orf72 is associated with autophagy, the inhibition of early stages of autophagosome formation by 3-MA could lead to a functional inhibition of C6orf72-mediated autophagy. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K/Akt pathway. C6orf72 has been linked to cell signaling that involves the PI3K/Akt pathway. Inhibition of this pathway by LY294002 can lead to reduced activity of C6orf72 in its signaling context. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that prevents the phosphorylation and activation of proteins downstream of PI3K, such as Akt. As C6orf72 is suggested to be involved in PI3K/Akt pathway signaling, wortmannin's inhibition of this pathway can lead to a functional inhibition of C6orf72. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Spautin-1 is known to promote the degradation of class III PI3 kinase Vps34, which is involved in the initiation of autophagy. Since C6orf72 is associated with the autophagy process, Spautin-1 can lead to the inhibition of autophagy-related functions of C6orf72 by reducing Vps34 activity. | ||||||
Saracatinib | 379231-04-6 | sc-364607 sc-364607A | 10 mg 200 mg | $115.00 $1056.00 | 7 | |
Saracatinib is a Src kinase inhibitor. Src kinase can phosphorylate various substrates involved in different signaling pathways, including those related to autophagy and cytoskeletal dynamics. Since C6orf72 may operate within these pathways, Saracatinib can inhibit these functions, indirectly inhibiting C6orf72. | ||||||
INK 128 | 1224844-38-5 | sc-364511 sc-364511A | 5 mg 50 mg | $321.00 $1835.00 | ||
Sapanisertib inhibits mTOR, a key regulator of autophagy and lysosome biogenesis. C6orf72 is involved in the regulation of autophagic processes, thus the inhibition of mTOR by Sapanisertib can functionally inhibit the autophagic pathway that involves C6orf72. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a V-ATPase inhibitor that blocks the acidification of lysosomes and autophagosome-lysosome fusion, which are critical steps in autophagy. C6orf72 is implicated in autophagic processes, so inhibition of lysosomal function by Bafilomycin A1 could inhibit C6orf72-related autophagic activities. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is a compound that raises the pH in lysosomes, impairing autophagosome-lysosome fusion and autophagic degradation. C6orf72 has a role in autophagy, so by inhibiting lysosomal function, Chloroquine can functionally inhibit the autophagic processes in which C6orf72 is involved. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin, and by doing so, it can modulate cellular signaling pathways that involve calcium signaling. Since C6orf72 has been associated with cellular signaling, inhibiting calcineurin with Cyclosporin A could indirectly lead to functional inhibition of C6orf72 activities in these pathways. | ||||||